{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:15:36Z","timestamp":1792721736036,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s40263-022-00918-0","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T13:14:46Z","timestamp":1650633286000},"page":"411-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation"],"prefix":"10.1007","volume":"36","author":[{"given":"Ajna","family":"Hamidovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"issue":"9119","key":"918_CR1","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0140-6736(97)07541-7","volume":"351","author":"A Ott","year":"1998","unstructured":"Ott A, Slooter AJC, Hofman A, van Harskamp F, Witteman JCM, Van Broeckhoven C, et al. Smoking and risk of dementia and Alzheimer\u2019s disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998;351(9119):1840\u20133.","journal-title":"Lancet"},{"issue":"9861","key":"918_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0140-6736(12)61720-6","volume":"381","author":"K Pirie","year":"2013","unstructured":"Pirie K, Peto R, Reeves GK, Green J, Beral V. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133\u201341.","journal-title":"Lancet"},{"issue":"9971","key":"918_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(14)60446-3","volume":"385","author":"DS Postma","year":"2015","unstructured":"Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385(9971):899\u2013909.","journal-title":"Lancet"},{"issue":"4","key":"918_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMsa1211127","volume":"368","author":"MJ Thun","year":"2013","unstructured":"Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368(4):351\u201364.","journal-title":"N Engl J Med"},{"key":"918_CR5","unstructured":"Prevention CfDCa. Promoting Quitting Among Adults and Young People: Outcome Indicators for Comprehensive Tobacco Control Programs\u20142015. 2015 [cited; Available from:"},{"issue":"6","key":"918_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/aje\/kwj231","volume":"164","author":"L Zhang","year":"2006","unstructured":"Zhang L, Samet J, Caffo B, Punjabi NM. Cigarette smoking and nocturnal sleep architecture. Am J Epidemiol. 2006;164(6):529\u201337.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"918_CR7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.sleep.2012.06.026","volume":"13","author":"A Jaehne","year":"2012","unstructured":"Jaehne A, Unbehaun T, Feige B, Lutz UC, Batra A, Riemann D. How smoking affects sleep: a polysomnographical analysis. Sleep Med. 2012;13(10):1286\u201392.","journal-title":"Sleep Med"},{"issue":"4430","key":"918_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1126\/science.7352268","volume":"207","author":"CR Soldatos","year":"1980","unstructured":"Soldatos CR, Kales JD, Scharf MB, Bixler EO, Kales A. Cigarette smoking associated with sleep difficulty. Science. 1980;207(4430):551\u20133.","journal-title":"Science"},{"issue":"9","key":"918_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.sleep.2008.12.008","volume":"10","author":"C Sahlin","year":"2009","unstructured":"Sahlin C, Franklin KA, Stenlund H, Lindberg E. Sleep in women: normal values for sleep stages and position and the effect of age, obesity, sleep apnea, smoking, alcohol and hypertension. Sleep Med. 2009;10(9):1025\u201330.","journal-title":"Sleep Med"},{"issue":"4","key":"918_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/archinte.164.4.406","volume":"164","author":"S Redline","year":"2004","unstructured":"Redline S, Kirchner HL, Quan SF, Gottlieb DJ, Kapur V, Newman A. The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch Intern Med. 2004;164(4):406\u201318.","journal-title":"Arch Intern Med"},{"issue":"2","key":"918_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/15402002.2018.1546707","volume":"18","author":"A Cohen","year":"2020","unstructured":"Cohen A, Ben Abu N, Haimov I, Cohen A, Ben Abu N, Haimov I. The interplay between tobacco dependence and sleep quality among young adults. Behav Sleep Med. 2020;18(2):163\u201376.","journal-title":"Behav Sleep Med"},{"issue":"3","key":"918_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1006\/pmed.1994.1046","volume":"23","author":"DW Wetter","year":"1994","unstructured":"Wetter DW, Young TB. The relation between cigarette smoking and sleep disturbance. Prev Med. 1994;23(3):328\u201334.","journal-title":"Prev Med"},{"issue":"4","key":"918_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/adb.12151","volume":"20","author":"A Jaehne","year":"2015","unstructured":"Jaehne A, Unbehaun T, Feige B, Cohrs S, Rodenbeck A, Sch\u00fctz AL, et al. Sleep changes in smokers before, during and 3 months after nicotine withdrawal. Addict Biol. 2015;20(4):747\u201355.","journal-title":"Addict Biol"},{"issue":"1","key":"918_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/16066359.2016.1190342","volume":"25","author":"NA Short","year":"2017","unstructured":"Short NA, Mathes BM, Gibby B, Oglesby ME, Zvolensky MJ, Schmidt NB. Insomnia symptoms as a risk factor for cessation failure following smoking cessation treatment. Addict Res Theory. 2017;25(1):17\u201323.","journal-title":"Addict Res Theory"},{"issue":"2","key":"918_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/jsc.2016.11","volume":"12","author":"RL Ashare","year":"2017","unstructured":"Ashare RL, Lerman C, Tyndale RF, Hawk LW, George TP, Cinciripini P, et al. Sleep disturbance during smoking cessation: withdrawal or side effect of treatment? J Smok Cessat. 2017;12(2):63\u201370.","journal-title":"J Smok Cessat"},{"issue":"5","key":"918_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","volume":"13","author":"D Michelson","year":"2014","unstructured":"Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, et al. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13(5):461\u201371.","journal-title":"Lancet Neurol"},{"key":"918_CR17","first-page":"82","volume":"1","author":"L Citrome","year":"2021","unstructured":"Citrome L, Juday T, Frech F, Atkins N Jr. Lemborexant for the treatment of insomnia: direct and indirect comparisons with other hypnotics using number needed to treat, number needed to harm, and likelihood to be helped or harmed. J Clin Psychiatry. 2021;1:82.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"918_CR18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.tins.2021.09.002","volume":"44","author":"JB Mehr","year":"2021","unstructured":"Mehr JB, Bilotti MM, James MH. Orexin (hypocretin) and addiction. Trends Neurosci. 2021;44(11):852\u20135.","journal-title":"Trends Neurosci"},{"issue":"5","key":"918_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12160-016-9797-5","volume":"50","author":"F Patterson","year":"2016","unstructured":"Patterson F, Malone SK, Lozano A, Grandner MA, Hanlon AL. Smoking, screen-based sedentary behavior, and diet associated with habitual sleep duration and chronotype: data from the UK biobank. Ann Behav Med. 2016;50(5):715\u201326.","journal-title":"Ann Behav Med"},{"key":"918_CR20","doi-asserted-by":"publisher","first-page":"101544","DOI":"10.1016\/j.smrv.2021.101544","volume":"60","author":"S Catoire","year":"2021","unstructured":"Catoire S, Nourredine M, Lefebvre S, Couraud S, Gronfier C, Rey R, et al. Tobacco-induced sleep disturbances: a systematic review and meta-analysis. Sleep Med Rev. 2021;60:101544.","journal-title":"Sleep Med Rev"},{"issue":"6","key":"918_CR21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/14622200412331324938","volume":"6","author":"IM Colrain","year":"2004","unstructured":"Colrain IM, Trinder J, Swan GE. The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations. Nicotine Tob Res. 2004;6(6):913\u201325.","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"918_CR22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/archinte.1995.00430070088011","volume":"155","author":"BA Phillips","year":"1995","unstructured":"Phillips BA, Danner FJ. Cigarette smoking and sleep disturbance. Arch Intern Med. 1995;155(7):734\u20137.","journal-title":"Arch Intern Med"},{"key":"918_CR23","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). 2013."},{"issue":"4","key":"918_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0306-4603(85)90034-6","volume":"10","author":"KM Cummings","year":"1985","unstructured":"Cummings KM, Giovino G, Ja\u00e9n CR, Emrich LJ. Reports of smoking withdrawal symptoms over a 21 day period of abstinence. Addict Behav. 1985;10(4):373\u201381.","journal-title":"Addict Behav"},{"issue":"3","key":"918_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14622200701188919","volume":"9","author":"JR Hughes","year":"2007","unstructured":"Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9(3):315\u201327.","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"918_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.addbeh.2011.03.001","volume":"36","author":"ML Okun","year":"2011","unstructured":"Okun ML, Levine MD, Houck P, Perkins KA, Marcus MD. Subjective sleep disturbance during a smoking cessation program: associations with relapse. Addict Behav. 2011;36(8):861\u20134.","journal-title":"Addict Behav"},{"issue":"3","key":"918_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/14622200701188901","volume":"9","author":"A Moreno-Couti\u00f1o","year":"2007","unstructured":"Moreno-Couti\u00f1o A, Calder\u00f3n-Ezquerro C, Drucker-Col\u00edn R. Long-term changes in sleep and depressive symptoms of smokers in abstinence. Nicotine Tob Res. 2007;9(3):389\u201396.","journal-title":"Nicotine Tob Res"},{"key":"918_CR28","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1111\/j.1360-0443.2006.01635.x","volume":"101","author":"S Shiffman","year":"2006","unstructured":"Shiffman S, Patten C, Gwaltney C, Paty J, Gnys M, Kassel J, et al. Natural history of nicotine withdrawal. Addiction. 2006;101:1822\u201332.","journal-title":"Addiction"},{"issue":"10","key":"918_CR29","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.brat.2004.08.008","volume":"43","author":"DS Mennin","year":"2005","unstructured":"Mennin DS, Heimberg RG, Turk CL, Fresco DM. Preliminary evidence for an emotion dysregulation model of generalized anxiety disorder. Behav Res Ther. 2005;43(10):1281\u2013310.","journal-title":"Behav Res Ther"},{"key":"918_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.addbeh.2016.01.013","volume":"57","author":"J Fillo","year":"2016","unstructured":"Fillo J, Alfano CA, Paulus DJ, Smits JA, Davis ML, Rosenfield D, et al. Emotion dysregulation explains relations between sleep disturbance and smoking quit-related cognition and behavior. Addict Behav. 2016;57:6\u201312.","journal-title":"Addict Behav"},{"key":"918_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.addbeh.2017.03.011","volume":"72","author":"BY Kauffman","year":"2017","unstructured":"Kauffman BY, Farris SG, Alfano CA, Zvolensky MJ. Emotion dysregulation explains the relation between insomnia symptoms and negative reinforcement smoking cognitions among daily smokers. Addict Behav. 2017;72:33\u201340.","journal-title":"Addict Behav"},{"issue":"12","key":"918_CR32","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1093\/ntr\/nts006","volume":"14","author":"J MacKillop","year":"2012","unstructured":"MacKillop J, Brown CL, Stojek MK, Murphy CM, Sweet L, Niaura RS. Behavioral economic analysis of withdrawal- and cue-elicited craving for tobacco: an initial investigation. Nicotine Tob Res. 2012;14(12):1426\u201334.","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"918_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/jcp.0b013e3181602fab","volume":"28","author":"A Hamidovic","year":"2008","unstructured":"Hamidovic A, Kang UJ, de Wit H. Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol. 2008;28(1):45\u201351.","journal-title":"J Clin Psychopharmacol"},{"key":"918_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.addbeh.2016.11.004","volume":"66","author":"MR Peltier","year":"2017","unstructured":"Peltier MR, Lee J, Ma P, Businelle MS, Kendzor DE. The influence of sleep quality on smoking cessation in socioeconomically disadvantaged adults. Addict Behav. 2017;66:7\u201312.","journal-title":"Addict Behav"},{"issue":"2","key":"918_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4187\/respcare.04958","volume":"62","author":"F Patterson","year":"2017","unstructured":"Patterson F, Zaslav DS, Kolman-Taddeo D, Cuesta H, Morrison M, Leone FT, et al. Smoking cessation in pulmonary care subjects: a mixed methods analysis of treatment-seeking participation and preferences. Respir Care. 2017;62(2):179\u201392.","journal-title":"Respir Care"},{"issue":"2","key":"918_CR36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1037\/a0023128","volume":"25","author":"EN Peters","year":"2011","unstructured":"Peters EN, Fucito LM, Novosad C, Toll BA, O\u2019Malley SS. Effect of night smoking, sleep disturbance, and their co-occurrence on smoking outcomes. Psychol Addict Behav. 2011;25(2):312\u20139.","journal-title":"Psychol Addict Behav"},{"key":"918_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.paid.2015.10.054","volume":"90","author":"NA Short","year":"2016","unstructured":"Short NA, Babson KA, Schmidt NB, Knight CB, Johnson J, Bonn-Miller MO. Sleep and affective functioning: examining the association between sleep quality and distress tolerance among veterans. Personal Individ Diff. 2016;90:247\u201353.","journal-title":"Personal Individ Diff"},{"issue":"11","key":"918_CR38","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/ntr\/ntr179","volume":"13","author":"TE Dorner","year":"2011","unstructured":"Dorner TE, Trostl A, Womastek I, Groman E. Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program. Nicotine Tob Res. 2011;13(11):1068\u201375.","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"918_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1017\/jsc.2013.19.PMID:24995044;PMCID:PMC4076952","volume":"9","author":"LM Fucito","year":"2014","unstructured":"Fucito LM, Redeker NS, Ball SA, Toll BA, Ikomi JT, Carroll KM. Integrating a behavioural sleep intervention into smoking cessation treatment for smokers with insomnia: a randomised pilot study. J Smok Cessat. 2014;9(1):31\u20138. https:\/\/doi.org\/10.1017\/jsc.2013.19.PMID:24995044;PMCID:PMC4076952.","journal-title":"J Smok Cessat"},{"issue":"11","key":"918_CR40","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1360-0443.1994.tb03744.x","volume":"89","author":"JR Hughes","year":"1994","unstructured":"Hughes JR, Higgins ST, Bickel WK. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction. 1994;89(11):1461\u201370.","journal-title":"Addiction"},{"issue":"5","key":"918_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.smrv.2008.12.003","volume":"13","author":"A Jaehne","year":"2009","unstructured":"Jaehne A, Loessl B, B\u00e1rkai Z, Riemann D, Hornyak M. Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Med Rev. 2009;13(5):363\u201377.","journal-title":"Sleep Med Rev"},{"key":"918_CR42","unstructured":"Wellbutrin (brupropion hydrochloride) [package insert]. Greenville, NC: DSM Pharmaceuticals, Inc; 2020."},{"issue":"5","key":"918_CR43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11606-009-0926-8","volume":"24","author":"JB McClure","year":"2009","unstructured":"McClure JB, Swan GE, Jack L, Catz SL, Zbikowski SM, McAfee TA, et al. Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. J Gen Internal Med. 2009;24(5):563.","journal-title":"J Gen Internal Med"},{"issue":"1","key":"918_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2174\/1574886311207040282","volume":"11","author":"DA Drovandi","year":"2016","unstructured":"Drovandi DA, Chen CC, Glass DB. Adverse Effects Cause Varenicline Discontinuation: A Meta-Analysis. Curr Drug Saf. 2016;11(1):78\u201385.","journal-title":"Curr Drug Saf"},{"key":"918_CR45","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1136\/bmj.h1109","volume":"350","author":"KH Thomas","year":"2015","unstructured":"Thomas KH, Martin RM, Knipe DW, Higgins JPT, Gunnell D. Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ. 2015;350:1109.","journal-title":"BMJ"},{"issue":"6","key":"918_CR46","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2165\/00002018-199920060-00007","volume":"20","author":"SG Gourlay","year":"1999","unstructured":"Gourlay SG, Forbes A, Marriner T, McNeil JJ. Predictors and Timing of Adverse Experiences During Transdermal Nicotine Therapy. Drug Saf. 1999;20(6):545\u201355.","journal-title":"Drug Saf"},{"issue":"1","key":"918_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2021.7621","volume":"326","author":"RJ Courtney","year":"2021","unstructured":"Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP, et al. Effect of cytisine vs varenicline on smoking cessation: a randomized clinical trial. JAMA. 2021;326(1):56\u201364.","journal-title":"JAMA"},{"issue":"11","key":"918_CR48","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/add.14721","volume":"114","author":"P Tutka","year":"2019","unstructured":"Tutka P, Vinnikov D, Courtney RJ, Benowitz NL. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation. Addiction. 2019;114(11):1951\u201369.","journal-title":"Addiction"},{"issue":"10037","key":"918_CR49","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","volume":"387","author":"RM Anthenelli","year":"2016","unstructured":"Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507\u201320.","journal-title":"Lancet"},{"issue":"4","key":"918_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2015.19284","volume":"315","author":"TB Baker","year":"2016","unstructured":"Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, et al. Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks a randomized clinical trial. JAMA. 2016;315(4):371\u20139.","journal-title":"JAMA"},{"issue":"4","key":"918_CR51","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573\u201385.","journal-title":"Cell"},{"issue":"1","key":"918_CR52","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L De Lecea","year":"1998","unstructured":"De Lecea L, Kilduff TS, Peyron C, Gao XB, Foye PE, Danielson PE, et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998;95(1):322\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"918_CR53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1124\/jpet.117.241422","volume":"362","author":"CT Beuckmann","year":"2017","unstructured":"Beuckmann CT, Suzuki M, Ueno T, Nagaoka K, Arai T, Higashiyama H. In vitro and in silico characterization of lemborexant (E2006), a novel dual orexin receptor antagonist. J Pharmacol Exp Ther. 2017;362(2):287\u201395.","journal-title":"J Pharmacol Exp Ther"},{"issue":"15","key":"918_CR54","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1017\/S0033291721001033","volume":"51","author":"T Kishi","year":"2021","unstructured":"Kishi T, Matsuda Y, Sakuma K, Okuya M, Mishima K, Iwata N. Recurrence rates in stable bipolar disorder patients after drug discontinuation versus drug maintenance: a systematic review and meta-analysis\u2014corrigendum. Psychol Med. 2021;51(15):2730.","journal-title":"Psychol Med"},{"key":"918_CR55","unstructured":"Belsomra (suvorexant) [package insert]. Whitehouse Station, NJ: Merck Sharp & Dohme Corp.; 2021."},{"key":"918_CR56","unstructured":"Dayvigo (lemborexant) [package insert]. Woodcliff Lake, NJ: Eisai Inc.; 2021."},{"issue":"9","key":"918_CR57","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.5664\/jcsm.6116","volume":"12","author":"WJ Herring","year":"2016","unstructured":"Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, et al. Suvorexant in patients with insomnia: pooled analyses of three-month data from phase-3 randomized controlled clinical trials. J Clin Sleep Med. 2016;12(9):1215\u201325.","journal-title":"J Clin Sleep Med"},{"key":"918_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.sleep.2015.10.007","volume":"19","author":"E Snyder","year":"2016","unstructured":"Snyder E, Ma J, Svetnik V, Connor KM, Lines C, Michelson D, et al. Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data. Sleep Med. 2016;19:93\u2013100.","journal-title":"Sleep Med"},{"issue":"5","key":"918_CR59","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/npp.2011.310","volume":"37","author":"P Bettica","year":"2012","unstructured":"Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ. Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology. 2012;37(5):1224\u201333.","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"918_CR60","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1177\/0269881112448946","volume":"26","author":"P Hoever","year":"2012","unstructured":"Hoever P, de Haas SL, Dorffner G, Chiossi E, van Gerven JM, Dingemanse J. Orexin receptor antagonism: an ascending multiple-dose study with almorexant. J Psychopharmacol. 2012;26(8):1071\u201380.","journal-title":"J Psychopharmacol"},{"issue":"12","key":"918_CR61","doi-asserted-by":"publisher","first-page":"e1918254-e","DOI":"10.1001\/jamanetworkopen.2019.18254","volume":"2","author":"R Rosenberg","year":"2019","unstructured":"Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, et al. Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial. JAMA Netw Open. 2019;2(12):e1918254-e.","journal-title":"JAMA Netw Open"},{"key":"918_CR62","doi-asserted-by":"crossref","unstructured":"K\u00e4rpp\u00e4 M, Yardley J, Pinner K, Filippov G, Zammit G, Moline M, et al. Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2. Sleep. 2020;43(9).","DOI":"10.1093\/sleep\/zsaa123"},{"issue":"10","key":"918_CR63","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1080\/14656566.2021.1902987","volume":"22","author":"G Zammit","year":"2021","unstructured":"Zammit G, Krystal A. Evaluating lemborexant for the treatment of insomnia. Expert Opin Pharmacother. 2021;22(10):1235\u201343.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"918_CR64","doi-asserted-by":"publisher","first-page":"e206614","DOI":"10.1001\/jamanetworkopen.2020.6614","volume":"3","author":"JM Zeitzer","year":"2020","unstructured":"Zeitzer JM, Joyce DS, McBean A, Quevedo YL, Hernandez B, Holty JE. Effect of suvorexant vs placebo on total daytime sleep hours in shift workers: a randomized clinical trial. JAMA Netw Open. 2020;3(6):e206614.","journal-title":"JAMA Netw Open"},{"issue":"49","key":"918_CR65","doi-asserted-by":"publisher","first-page":"19480","DOI":"10.1073\/pnas.0808023105","volume":"105","author":"JA Hollander","year":"2008","unstructured":"Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci. 2008;105(49):19480\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"918_CR66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00213-010-1792-0","volume":"209","author":"MG LeSage","year":"2010","unstructured":"LeSage MG, Perry JL, Kotz CM, Shelley D, Corrigall WA. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. Psychopharmacology. 2010;209(2):203\u201312.","journal-title":"Psychopharmacology"},{"key":"918_CR67","first-page":"199","volume-title":"International review of neurobiology","author":"JR Barson","year":"2017","unstructured":"Barson JR, Leibowitz SF. Chapter eight\u2014orexin\/hypocretin system: role in food and drug overconsumption. In: Thiele TE, editor. International review of neurobiology. New York: Academic Press; 2017. p. 199\u2013237."},{"issue":"9","key":"918_CR68","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/npp.2013.72","volume":"38","author":"A Plaza-Zabala","year":"2013","unstructured":"Plaza-Zabala A, Flores \u00c1, Mart\u00edn-Garc\u00eda E, Saravia R, Maldonado R, Berrendero F. A role for hypocretin\/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior. Neuropsychopharmacology. 2013;38(9):1724\u201336.","journal-title":"Neuropsychopharmacology"},{"key":"918_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbr.2014.04.012","volume":"269","author":"JM Uslaner","year":"2014","unstructured":"Uslaner JM, Winrow CJ, Gotter AL, Roecker AJ, Coleman PJ, Hutson PH, et al. Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement. Behav Brain Res. 2014;269:61\u20135.","journal-title":"Behav Brain Res"},{"issue":"6","key":"918_CR70","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1523\/JNEUROSCI.5724-09.2010","volume":"30","author":"A Plaza-Zabala","year":"2010","unstructured":"Plaza-Zabala A, Martin-Garcia E, de Lecea L, Maldonado R, Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci. 2010;30(6):2300\u201310.","journal-title":"J Neurosci"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-022-00918-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T05:23:15Z","timestamp":1652246595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-022-00918-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1007\/s40263-022-00918-0","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"assertion":[{"value":"30 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was provided for the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The author declares no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AH formulated the idea for the article, performed the literature search, and drafted\/critically revised the work. The author read and approved the final submitted manuscript, and agrees to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}